PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
47.09
ESG score below 80% of SAVA's 63.11. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
27.98
Environmental score below 80% of SAVA's 63.13. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.14
Social score 90-95% of SAVA's 61.04. Bill Ackman would demand clear social improvement catalysts.
58.16
Governance score 80-90% of SAVA's 65.15. Walter Schloss would scrutinize management accountability and board independence.